30% off. Use code SUMMER30 at checkout for 30% off for 12 months on Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Encorium Group Inc (ENCO)

Track

Stock chart
Ticker: ENCO Exchange: PNK
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Koskelo Ilari
1 purchase — total 1,983,968 USD
Buy 27 Dec 2010
Value US$3,189,845.80 | Price 240.54 | Shares 24,779
Buy 19 Oct 2009
Value US$2,342,095.90 | Price 100.13 | Shares 53,730
Buy 27 Oct 2008
Value US$17,150,000.00 | Price 2,450.00 | Shares 7,000
Buy 1 Nov 2007
Value US$7,321.14 | Price 2.67 | Shares 2,742
Sale 26 Oct 2007
Value US$310.00 | Price 3.10 | Shares 100
Sale 25 Oct 2007
Value US$20,550.00 | Price 3.00 | Shares 6,850
Buy 20 Aug 2007
Value US$48,791.58 | Price 2.67 | Shares 18,274
Sale 31 May 2007
Value US$4,000.00 | Price 3.20 | Shares 1,250
Sale 25 May 2007
Value US$32,643.00 | Price 3.00 | Shares 10,881
Sale 25 May 2007
Value US$301.00 | Price 3.01 | Shares 100
Sale 25 May 2007
Value US$604.00 | Price 3.02 | Shares 200
Sale 25 May 2007
Value US$10,732.95 | Price 3.05 | Shares 3,519
Sale 25 May 2007
Value US$6,820.00 | Price 3.10 | Shares 2,200
Planned sale 14 Mar 2007
Value US$56,910.00 | Price 4.07 | Shares 14,000
Planned sale 13 Feb 2007
Value US$241,605.00 | Price 4.83 | Shares 50,000
Planned sale 13 Nov 2006
Value US$95,080.00 | Price 3.80 | Shares 25,000
Planned sale 2 Nov 2006
Value US$55,284.00 | Price 3.69 | Shares 15,000
Sale 26 Oct 2006
Value US$110,790.90 | Price 3.57 | Shares 31,000
Sale 27 May 2004
Value US$5,100.00 | Price 3.40 | Shares 1,500
Sale 27 May 2004
Value US$13,640.00 | Price 3.41 | Shares 4,000
Sale 27 May 2004
Value US$7,476.15 | Price 3.45 | Shares 2,167
Sale 27 May 2004
Value US$3,550.00 | Price 3.55 | Shares 1,000
Sale 27 May 2004
Value US$14,400.00 | Price 3.60 | Shares 4,000
Sale 27 May 2004
Value US$9,025.00 | Price 3.61 | Shares 2,500
Sale 26 May 2004
Value US$5,550.00 | Price 3.70 | Shares 1,500
Sale 20 May 2004
Value US$20,625.00 | Price 3.75 | Shares 5,500
Sale 20 May 2004
Value US$9,425.00 | Price 3.77 | Shares 2,500
Sale 20 May 2004
Value US$29,830.00 | Price 3.80 | Shares 7,850
Sale 20 May 2004
Value US$2,667.00 | Price 3.81 | Shares 700
Sale 19 May 2004
Value US$1,885.00 | Price 3.77 | Shares 500
Sale 19 May 2004
Value US$1,880.00 | Price 3.76 | Shares 500
Sale 19 May 2004
Value US$3,800.00 | Price 3.80 | Shares 1,000
Sale 19 May 2004
Value US$15,000.00 | Price 3.75 | Shares 4,000
Sale 18 May 2004
Value US$1,885.00 | Price 3.77 | Shares 500
Sale 18 May 2004
Value US$40,660.00 | Price 3.80 | Shares 10,700
Sale 18 May 2004
Value US$10,287.00 | Price 3.81 | Shares 2,700
Sale 14 May 2004
Value US$40,376.00 | Price 3.92 | Shares 10,300
Planned sale 23 Apr 2004
Value US$24,800.00 | Price 4.00 | Shares 6,200
Planned sale 23 Apr 2004
Value US$10,942.42 | Price 4.00 | Shares 2,738
Planned sale 23 Apr 2004
Value US$76,479.90 | Price 3.95 | Shares 19,362
Planned sale 22 Apr 2004
Value US$85,715.00 | Price 3.95 | Shares 21,700
Planned sale 2 Apr 2004
Value US$8,573.00 | Price 3.43 | Shares 2,500
Planned sale 2 Apr 2004
Value US$98,260.00 | Price 3.40 | Shares 28,900
Planned sale 1 Apr 2004
Value US$63,240.00 | Price 3.40 | Shares 18,600
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2010-12-29 2010-12-27 B Purchase Koskelo Ilari Large shareholder
24,779 +44.4%
240.54
US$3,189,846 		24,779 +44.4% 240.54 US$3,189,846
2009-10-20 2009-10-19 B Purchase Koskelo Ilari Large shareholder
53,730 -19.6%
100.13
US$2,342,096 		53,730 -19.6% 100.13 US$2,342,096
2008-10-28 2008-10-27 B Purchase Lindevall Kai Eugen Harald

Pres. European and Asian Oper.

Executive Director
4,255 +43.2%
416.92
US$3,893,340 		4,255 +43.2% 416.92 US$3,893,340
2007-11-02 2007-11-01 B Purchase Manninen Petri Mikael Non-Executive Director
2,742 +4.1%
2.67
US$7,321 		2,742 +4.1% 2.67 US$7,321
2007-10-29 2007-10-26 S Sale ONEILL ALISON

Senior Vice President

Officer
100 -100.0%
3.10
US$310 		100 -100.0% 3.10 US$310
2007-10-29 2007-10-25 S Sale ONEILL ALISON

Senior Vice President

Officer
6,850 -100.0%
3.00
US$20,550 		6,850 -100.0% 3.00 US$20,550
2007-08-22 2007-08-20 B Purchase Manninen Petri Mikael Non-Executive Director
18,274 +38.0%
2.67
US$48,792 		18,274 +38.0% 2.67 US$48,792
2007-06-04 2007-05-31 S Sale ONEILL ALISON

Senior Vice President

Officer
1,250 -100.0%
3.20
US$4,000 		1,250 -100.0% 3.20 US$4,000
2007-05-30 2007-05-25 S Sale ONEILL ALISON

Senior Vice President

Officer
10,881 -100.0%
3.00
US$32,643 		10,881 -100.0% 3.00 US$32,643
2007-05-30 2007-05-25 S Sale ONEILL ALISON

Senior Vice President

Officer
100 -0.9%
3.01
US$301 		100 -0.9% 3.01 US$301
2007-05-30 2007-05-25 S Sale ONEILL ALISON

Senior Vice President

Officer
200 -1.8%
3.02
US$604 		200 -1.8% 3.02 US$604
2007-05-30 2007-05-25 S Sale ONEILL ALISON

Senior Vice President

Officer
3,519 -23.9%
3.05
US$10,733 		3,519 -23.9% 3.05 US$10,733
2007-05-30 2007-05-25 S Sale ONEILL ALISON

Senior Vice President

Officer
2,200 -13.0%
3.10
US$6,820 		2,200 -13.0% 3.10 US$6,820
2007-03-15 2007-03-14 PlS Planned sale BOROW KENNETH M MD

President/CEO

Executive Director
14,000 -1.8%
4.07
US$56,910 		14,000 -1.8% 4.07 US$56,910
2007-02-14 2007-02-13 PlS Planned sale BOROW KENNETH M MD

President/CEO

Executive Director
50,000 -6.1%
4.83
US$241,605 		50,000 -6.1% 4.83 US$241,605
2006-11-15 2006-11-13 PlS Planned sale BOROW KENNETH M MD

President/CEO

Executive Director
25,000 -3.0%
3.80
US$95,080 		25,000 -3.0% 3.80 US$95,080
2006-11-03 2006-11-02 PlS Planned sale BOROW KENNETH M MD

President/CEO

Executive Director
15,000 -1.7%
3.69
US$55,284 		15,000 -1.7% 3.69 US$55,284
2006-10-30 2006-10-26 S Sale BOROW KENNETH M MD

President/CEO

Executive Director
31,000 -3.5%
3.57
US$110,791 		31,000 -3.5% 3.57 US$110,791
2004-05-28 2004-05-27 S Sale
HALL JOHN ROBERT

VP/Intn'l. Clinical Operations
1,500 -100.0%
3.40
US$5,100 		1,500 -100.0% 3.40 US$5,100
2004-05-28 2004-05-27 S Sale
HALL JOHN ROBERT

VP/Intn'l. Clinical Operations
4,000 -100.0%
3.41
US$13,640 		4,000 -100.0% 3.41 US$13,640
2004-05-28 2004-05-27 S Sale
HALL JOHN ROBERT

VP/Intn'l. Clinical Operations
2,167 -100.0%
3.45
US$7,476 		2,167 -100.0% 3.45 US$7,476
2004-05-28 2004-05-27 S Sale
HALL JOHN ROBERT

VP/Intn'l. Clinical Operations
1,000 -100.0%
3.55
US$3,550 		1,000 -100.0% 3.55 US$3,550
2004-05-28 2004-05-27 S Sale
HALL JOHN ROBERT

VP/Intn'l. Clinical Operations
4,000 -100.0%
3.60
US$14,400 		4,000 -100.0% 3.60 US$14,400
2004-05-28 2004-05-27 S Sale
HALL JOHN ROBERT

VP/Intn'l. Clinical Operations
2,500 -100.0%
3.61
US$9,025 		2,500 -100.0% 3.61 US$9,025
2004-05-27 2004-05-26 S Sale
HALL JOHN ROBERT

VP/Intn'l. Clinical Operations
1,500 -100.0%
3.70
US$5,550 		1,500 -100.0% 3.70 US$5,550
2004-05-21 2004-05-20 S Sale
HALL JOHN ROBERT

VP/Intn'l. Clinical Operations
5,500 -100.0%
3.75
US$20,625 		5,500 -100.0% 3.75 US$20,625
2004-05-21 2004-05-20 S Sale
HALL JOHN ROBERT

VP/Intn'l. Clinical Operations
2,500 -100.0%
3.77
US$9,425 		2,500 -100.0% 3.77 US$9,425
2004-05-21 2004-05-20 S Sale
HALL JOHN ROBERT

VP/Intn'l. Clinical Operations
7,850 -100.0%
3.80
US$29,830 		7,850 -100.0% 3.80 US$29,830
2004-05-21 2004-05-20 S Sale
HALL JOHN ROBERT

VP/Intn'l. Clinical Operations
700 -100.0%
3.81
US$2,667 		700 -100.0% 3.81 US$2,667
2004-05-20 2004-05-19 S Sale
HALL JOHN ROBERT

VP/Intn'l. Clinical Operations
500 -100.0%
3.77
US$1,885 		500 -100.0% 3.77 US$1,885
2004-05-20 2004-05-19 S Sale
HALL JOHN ROBERT

VP/Intn'l. Clinical Operations
500 -100.0%
3.76
US$1,880 		500 -100.0% 3.76 US$1,880
2004-05-20 2004-05-19 S Sale
HALL JOHN ROBERT

VP/Intn'l. Clinical Operations
1,000 -100.0%
3.80
US$3,800 		1,000 -100.0% 3.80 US$3,800
2004-05-20 2004-05-19 S Sale
HALL JOHN ROBERT

VP/Intn'l. Clinical Operations
4,000 -100.0%
3.75
US$15,000 		4,000 -100.0% 3.75 US$15,000
2004-05-19 2004-05-18 S Sale
HALL JOHN ROBERT

VP/Intn'l. Clinical Operations
500 -100.0%
3.77
US$1,885 		500 -100.0% 3.77 US$1,885
2004-05-19 2004-05-18 S Sale
HALL JOHN ROBERT

VP/Intn'l. Clinical Operations
10,700 -100.0%
3.80
US$40,660 		10,700 -100.0% 3.80 US$40,660
2004-05-19 2004-05-18 S Sale
HALL JOHN ROBERT

VP/Intn'l. Clinical Operations
2,700 -100.0%
3.81
US$10,287 		2,700 -100.0% 3.81 US$10,287
2004-05-18 2004-05-14 S Sale
HALL JOHN ROBERT

VP/Intn'l. Clinical Operations
10,300 -100.0%
3.92
US$40,376 		10,300 -100.0% 3.92 US$40,376
2004-04-26 2004-04-23 PlS Planned sale HODAPP THOMAS Non-Executive Director
6,200 -1.5%
4.00
US$24,800 		6,200 -1.5% 4.00 US$24,800
2004-04-26 2004-04-23 PlS Planned sale HODAPP THOMAS Non-Executive Director
2,738 -0.7%
4.00
US$10,942 		2,738 -0.7% 4.00 US$10,942
2004-04-26 2004-04-23 PlS Planned sale HODAPP THOMAS Non-Executive Director
19,362 -4.4%
3.95
US$76,480 		19,362 -4.4% 3.95 US$76,480
2004-04-26 2004-04-22 PlS Planned sale HODAPP THOMAS Non-Executive Director
21,700 -4.7%
3.95
US$85,715 		21,700 -4.7% 3.95 US$85,715
2004-04-05 2004-04-02 PlS Planned sale HODAPP THOMAS Non-Executive Director
2,500 -0.5%
3.43
US$8,573 		2,500 -0.5% 3.43 US$8,573
2004-04-05 2004-04-02 PlS Planned sale HODAPP THOMAS Non-Executive Director
28,900 -5.9%
3.40
US$98,260 		28,900 -5.9% 3.40 US$98,260
2004-04-05 2004-04-01 PlS Planned sale HODAPP THOMAS Non-Executive Director
18,600 -3.6%
3.40
US$63,240 		18,600 -3.6% 3.40 US$63,240
Explore more

More insider trading research around Encorium Group Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America